TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 10.15
+0.24 (2.42%)
At close: Mar 27, 2026
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 3.86 billion as of March 27, 2026. Its market cap has decreased by -64.80% in one year.
Market Cap
3.86B
Enterprise Value
3.61B
Revenue
117.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.15
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 3.86B, a decrease of -24.07%. That is a compound annual growth rate of -15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.86B | -22.58% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 5.02B |
| Beijing Luzhu Biotechnology | 4.77B |
| Viva Biotech Holdings | 4.12B |
| BioDlink International Company | 4.11B |
| Qyuns Therapeutics | 4.04B |
| Shandong Boan Biotechnology | 4.00B |
| Mirxes Holding Company | 3.75B |
| Clover Biopharmaceuticals | 3.41B |